NAMS
NewAmsterdam Pharma Company N.V.
stockNASDAQ
At CloseNov 6, 2026 3:59:59 PM EST
18.89USD0.000%(-0.00)1,705,174
Pre-marketNov 6, 2026 8:52:30 AM EST
19.25USD+1.906%(+0.36)
After-hoursNov 6, 2026 4:27:30 PM EST
18.90USD+0.053%(+0.01)
NAMS Financials
In Q3 FY 2026 (ended ), NewAmsterdam Pharma Company N.V. (NAMS) reported revenue of $19.16M, net income of −$17.39M, operating cash flow of −$39.77M, and assets of $687.99M (filed ).
Loading financial flows…